BURNETT PATRICK (See Remarks) sold 4.9% of their position (6.29K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $158.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001628280-26-014324
Officer· See Remarks
Since Aug 2020
+117.46K
Net shares
Net buyer
$158.3K
Total sold
2
Open market trades
0B · 2S
5
Total transactions
123.75K acquired · 6.29K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+16.75K
Price / share
—
Trade value
—
% of position
20.8%
8/18/2022
80.65K→97.40K
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
30.8%
2/27/2026
97.40K→127.40K
Common Stock
Direct
Shares
−6.11K
Price / share
$25.16
Trade value
$153.63K
% of position
4.8%
3/2/2026
127.40K→121.30K
Common Stock
Direct
Shares
−181.00
Price / share
$25.91
Trade value
$4.69K
% of position
0.1%
3/2/2026
121.33K→121.15K
Total
Net shares
+40.46K
Net value
-$158.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2022 | A · Award | +16.75K | — | — | 20.8% | 80.65K | 97.40K |
| Common Stock Direct | 2/27/2026 | A · Award | +30K | — | — | 30.8% | 97.40K | 127.40K |
| Common Stock Direct | 3/2/2026 | S · Sale | −6.11K | $25.16 | $153.63K | 4.8% | 127.40K | 121.30K |
| Common Stock Direct | 3/2/2026 | S · Sale | −181.00 | $25.91 | $4.69K | 0.1% | 121.33K | 121.15K |
| Total | +40.46K | -$158.32K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
77K shares
Shares
+77K
Strike price
26.97
Held after
77K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock77K shares | 2/27/2026 | A · Award | +77K | 26.97 | — | 77K |